Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Oxidative damage to mitochondria at the nodes of Ranvier precedes axon degeneration in ex vivo transected axons.
[Productivity and impact of Spanish research into multiple sclerosis (1996-2010)].
Current and emerging therapies for the treatment of multiple sclerosis: focus on cladribine.
[Pregnancy and multiple sclerosis -outcomes analysis 2003-2011].
"It gave me something big in my life to wonder and think about which took over the space … and not MS": managing well-being in multiple sclerosis through art-making.
Internal jugular and vertebral vein volume flow in patients with clinically isolated syndrome or mild multiple sclerosis and healthy controls: results from a prospective sonographer-blinded study.
Towards patient collaboration in cognitive assessment: Specificity, sensitivity, and incremental validity of self-report.
Massive peripheral nerve hypertrophy in a patient with chronic inflammatory demyelinating polyradiculoneuropathy.
Relative changes in ankle and hip control during bilateral joint movements in persons with multiple sclerosis.
Iron chelation in the treatment of neurodegenerative diseases.
OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages.
Pediatric familial neuromyelitis optica in two sisters with long term follow-up.
Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series.
Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.
Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM.
Association between smoking and cognitive impairment in multiple sclerosis.
Targeting the low-hanging fruit of neurodegeneration.
Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis.
Multiple sclerosis in the far north - incidence and prevalence in Nordland County, Norway, 1970¿2010.
Difference in Motor Fatigue between Patients with Stroke and Patients with Multiple Sclerosis: A Pilot Study.
Accuracy and Reproducibility of a Quantitative Magnetic Resonance Imaging Method for Concurrent Measurements of Tissue Relaxation Times and Proton Density.
Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis.
"Response to the Commentary on "Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin"
A Randomized Controlled Pilot Trial: The Effects of EGb 761 on Information Processing and Executive Function in Multiple Sclerosis.
[Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].
Pages
« first
‹ previous
…
530
531
532
533
534
535
536
537
538
…
next ›
last »